tiprankstipranks
Krystal Biotech, Inc. (KRYS)
NASDAQ:KRYS
US Market
KRYS
Krystal Biotech
RESEARCH TOOLSreports
Want to see KRYS full AI Analyst Report?

Krystal Biotech (KRYS) Income Statement

637 Followers

Krystal Biotech Income Statement

Last quarter (Q4 2025), Krystal Biotech's total revenue was $107.11M, an increase of 17.52% from the same quarter last year. In Q4, Krystal Biotech's net income was $51.40M. See Krystal Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 389.13M$ 290.51M$ 50.70M$ 0.00$ 0.00
Gross Profit
$ 360.36M$ 270.45M$ 47.60M$ 0.00$ 0.00
Operating Expenses
$ 199.06M$ 204.76M$ 157.33M$ 145.20M$ 68.28M
Depreciation and Amortization
$ 6.55M$ 6.71M$ 5.91M$ 3.38M$ 1.85M
EBITDA
$ 167.85M$ 109.91M$ -91.32M$ -116.81M$ -66.23M
Operating Income
$ 161.29M$ 65.69M$ -109.73M$ -145.20M$ -68.28M
Other Income/Expenses
$ 28.18M$ 29.66M$ 122.62M$ 5.22M$ -1.29M
Pretax Income
$ 189.47M$ 95.36M$ 12.90M$ -139.97M$ -69.57M
Net Income
$ 204.83M$ 89.16M$ 10.93M$ -139.97M$ -69.57M
Per Share Metrics
Basic EPS
$ 7.08$ 3.12$ 0.40$ -5.49$ -3.13
Diluted EPS
$ 6.84$ 3.00$ 0.39$ -5.49$ -3.13
Weighted Average Shares Outstanding
 28.94M 28.59M 27.15M 25.49M 22.20M
Weighted Average Shares Outstanding (Diluted)
 29.95M 29.74M 27.75M 25.49M 22.20M
Currency in USD

Krystal Biotech Earnings and Revenue History